Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-A-crystallin is a small heat shock protein that comprises approximately 40% of the dry weight of the mammalian eye lens and exists in a 3:1 ratio with alpha-B-crystallin. This 19.8 kDa protein functions as a molecular chaperone, binding to misfolded and denatured proteins to prevent their aggregation and precipitation, which would otherwise cause lens opacity and cataract formation. Alpha-A-crystallin is composed of 173 amino acids organized predominantly in beta-sheet structures, with a conserved alpha-crystallin domain (~90 amino acids) flanked by variable N-terminal and C-terminal regions. The protein's chaperone activity is central to maintaining lens transparency throughout life, as it suppresses the formation of light-scattering protein complexes under a range of physiological and stress conditions including elevated temperature, oxidative stress, and pH changes. While not a classical drug target, alpha-A-crystallin has been intensively studied for over 50 years because therapeutic strategies aimed at preserving or enhancing its chaperone function could potentially prevent or delay cataract formation, the leading cause of blindness worldwide.
Chaperone-mediated prevention of protein aggregation through binding to unfolded or denatured proteins\nSuppression of light-scattering aggregates that cause lens opacity\nStabilization of other crystallins (beta and gamma crystallins) under denaturing and physiological conditions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-A-crystallin (also known as Alpha-crystallin A subunit or Heat shock protein beta-4) (αA-crystallin or HSPB4).